Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
Aesthetic Dermatology
Have you used topical rapamycin/sirolimus for TSC-related angiofibromas?
Wataya-Kaneda et al., PMID 27837201
Answer from: at Community Practice
I used it before it was approved for the treatment of vascular lesions and noted that it was effective and safe.
Comments
at North Atlanta Dermatology Duluth
What is the percentage you use? I have not found i...
14607
Sign in or Register to read more
Answer from: at Academic Institution
I have used it in 4 patients, and it is more effective over ablative laser treatment of lesions or fractional ablative laser for better drug delivery.
Sign in or Register to read more
Answer from: at Community Practice
It works well and is very safe.
Sign in or Register to read more
25067
25030
25241
Related Questions
What cosmetic treatments have you had success with in treating dermatofibromas?
For patients on medications that are known to cause photosensitivity, would you counsel them to avoid laser hair removal or laser therapies?
How would you counsel a patient with systemic sclerosis who wants to consider microneedling on the face or other skin which is not clearly involved with scleroderma?
What’s your immediate post procedure protocol for fractionated laser resurfacing (ie Sciton Pro-fractional Laser)?
How do you approach the timing of skin tightening interventions in patients who experience significant weight loss to optimize both intermediate and long-term aesthetic outcomes?
How do you approach cosmetic removals of labial melanocytic macules?
How do you weigh the risks of intraocular eye shields when performing CO2 laser to the eyelids and periocular area?
What have you found to be effective for keratosis pilaris?
Would you consider prophylactic metformin as an anti-aging treatment?
Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?
What is the percentage you use? I have not found i...